Literature DB >> 16415496

Coronary microvascular dysfunction and idiopathic dilated cardiomyopathy.

Danilo Neglia1, Antonio L'Abbate.   

Abstract

There is growing evidence of the presence and relevance of coronary microvascular abnormalities in many cardiac diseases. In particular, it has been recently shown that dilated cardiomyopathy (DCM) is characterized by dysfunction of the coronary microvessels since its very early onset. Coronary microcirculatory dysfunction is not an effect of myocardial damage but seems in turn to cause progressive contractile impairment, ventricular dilation and heart failure. The mechanisms of the progressive deterioration of cardiac function in DCM are largely unknown but both myocardial hypoperfusion and myocardial ischemia at the microvascular level are most probably involved. It has been demonstrated that the presence and the extent of coronary microcirculatory dysfunction in patients with early stage DCM is an independent and relevant predictor of worse prognosis. From these studies it is more and more evident that the coronary microcirculation is involved in the pathogenesis ofDCMand should be considered a new target of treatment in those cardiac diseases at risk to evolve towards heart failure.

Entities:  

Mesh:

Year:  2005        PMID: 16415496

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  6 in total

1.  Positron emission tomography: An additional prognostic tool in dilated cardiomyopathy?

Authors:  Danilo Neglia
Journal:  J Nucl Cardiol       Date:  2015-08-22       Impact factor: 5.952

2.  Evaluation of left ventricular volumes and ejection fraction by gated SPECT and cardiac MRI in patients with dilated cardiomyopathy.

Authors:  Feng Wang; Jian Zhang; Wei Fang; Shi-Hua Zhao; Min-Jie Lu; Zuo-Xiang He
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-18       Impact factor: 9.236

3.  Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure.

Authors:  Daniela Giannessi; Chiara Caselli; Silvia Del Ry; Maristella Maltinti; Silvia Pardini; Stefano Turchi; Manuela Cabiati; Tiziana Sampietro; Nader Abraham; Antonio L'abbate; Danilo Neglia
Journal:  Metabolism       Date:  2010-03-04       Impact factor: 8.694

4.  Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identified by novel perfusion CT.

Authors:  Wayne L Miller; Thomas R Behrenbeck; Cynthia H McCollough; Eric E Williamson; Shuai Leng; Timothy L Kline; Erik L Ritman
Journal:  Int J Cardiovasc Imaging       Date:  2015-02-25       Impact factor: 2.357

Review 5.  The Importance of Integrated Regulation Mechanism of Coronary Microvascular Function for Maintaining the Stability of Coronary Microcirculation: An Easily Overlooked Perspective.

Authors:  Houyong Zhu; Hanxin Wang; Xinyu Zhu; Qilan Chen; Xiaojiang Fang; Xiaoqun Xu; Yan Ping; Beibei Gao; Guoxin Tong; Yu Ding; Tielong Chen; Jinyu Huang
Journal:  Adv Ther       Date:  2022-10-24       Impact factor: 4.070

6.  Traditional chinese medicine tongxinluo improves cardiac function of rats with dilated cardiomyopathy.

Authors:  Fang-Fang Shen; Ting-Hui Jiang; Jin-Qi Jiang; Ying Lou; Xu-Min Hou
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-28       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.